Hepatoblastoma in low birth weight infants: an institutional review.
The association between hepatoblastoma and low birth weight documented recently in the literature has yet to be well explained, in particular the suggestion that these patients may have a more aggressive form of the disease. From 1989 to 2003, our institution treated four patients for hepatoblastoma who had birth weights of less than 1,500 g. Notable was 100% patient survival despite bilateral and, in one case, recurrent disease. Speculation regarding the etiology of this subset of hepatoblastoma has included damage to developing hepatocytes induced by oxygen free radicals. Our patients universally had pulmonary disease requiring prolonged supplemental oxygen and ventilatory support. However, our review supports no changes in the standard care of low birth weight infants or in managing those who develop hepatoblastoma.
Kapfer
Stephanie A
SA
Division of Pediatric Surgery, Department of Surgery, State University of New York at Buffalo, The Women and Children's Hospital of Buffalo, Buffalo, NY 14222, USA.
Petruzzi
Mary Jane
MJ
Caty
Michael G
MG
D001997:Bronchopulmonary Dysplasia / Q000150:complications; D018572:Disease-Free Survival; D004374:Ductus Arteriosus, Patent / Q000150:complications; D005500:Follow-Up Studies; D018197:Hepatoblastoma / Q000473:pathology*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000473:pathology*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010102:Oxygen Inhalation Therapy; D012189:Retrospective Studies; D016896:Treatment Outcome